Duodenoscope Studies Find Higher-Than-Expected Contamination Rates

FDA issued the interim results of agency-mandated duodenoscope reprocessing studies to help inform hospitals and health care facilities of the need to carefully clean and properly maintain the devices, the agency said Monday (Dec. 10). The interim report found higher-than-expected contamination rates after reprocessing, with especially high rates of high-concern organisms, which are associated with diseases such as E. coli and Staphylococcus aureus (staph), FDA device center head Jeff Shuren says in a press statement. FDA has been...